Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Depreciation & Amortization (CF): 2019-2024

Historic Depreciation & Amortization (CF) for Molecular Partners Ag (MOLN) over the last 6 years, with Dec 2024 value amounting to $2.7 million.

  • Molecular Partners Ag's Depreciation & Amortization (CF) rose 0.93% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year decrease of 0.46%. This contributed to the annual value of $2.7 million for FY2024, which is 0.06% down from last year.
  • Molecular Partners Ag's Depreciation & Amortization (CF) amounted to $2.7 million in FY2024, which was down 0.06% from $2.7 million recorded in FY2023.
  • Molecular Partners Ag's Depreciation & Amortization (CF)'s 5-year high stood at $3.2 million during FY2020, with a 5-year trough of $2.5 million in FY2022.
  • In the last 3 years, Molecular Partners Ag's Depreciation & Amortization (CF) had a median value of $2.7 million in 2024 and averaged $2.6 million.
  • In the last 5 years, Molecular Partners Ag's Depreciation & Amortization (CF) increased by 28.47% in 2020 and then decreased by 12.89% in 2021.
  • Molecular Partners Ag's Depreciation & Amortization (CF) (Yearly) stood at $3.2 million in 2020, then declined by 12.89% to $2.8 million in 2021, then dropped by 10.89% to $2.5 million in 2022, then increased by 8.70% to $2.7 million in 2023, then dropped by 0.06% to $2.7 million in 2024.